No­var­tis vet O'­Dowd takes the helm at Neon; FDA slaps a hold on Cel-Sci's PhI­II can­cer study

Cam­bridge, MA-based Neon Ther­a­peu­tics is cel­e­brat­ing its first birth­day with a new CEO ap­point­ment. In clas­sic Third Rock fash­ion the neoanti­gen biotech got start­ed with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER